Metabolism of lysergic acid diethylamide (LSD): an update.
Libânio Osório Marta, R. F. | Drug metabolism reviews | 16 July 2019
Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
Pallavicini, C., Vilas, M. G., Villarreal, M., Zamberlan, F., Muthukumaraswamy, S., Nutt, D., & Tagliazucchi, E. | NeuroImage | 24 June 2019
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.
Holze, F., Duthaler, U., Vizeli, P., Müller, F., Borgwardt, S., & Liechti, M. E. | British journal of clinical pharmacology | 29 Apr 2019
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use
Luethi, D., Hoener, M. C., Krähenbühl, S., Liechti, M. E., & Duthaler, U. | Biochemical pharmacology | 11 April 2019
Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
Dipasquale, O., Selvaggi, P., Veronese, M., Gabay, A. S., Turkheimer, F., Mehta, M. A. | NeuroImage | 4 April 2019
Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action
Coffeen, U., & Pellicer, F. | Journal of pain research | 22 March 2019